Thursday, Bayer shared top-line data from a phase 3 trial that tested elinzanetant in women on adjuvant endocrine therapy for ...

According to GlobalData, Pre-Registration drugs for Vasomotor Symptoms of Menopause (Hot Flashes) have a 75% phase transition success rate (PTSR) indication benchmark for progressing into Marketed.

Because of this definition, they have not been subject to reports of efficacy and adverse events compared with US FDA-approved hormones ... Evidence for Relief of Hot Flashes & Vaginal Dryness ...

According to GlobalData, Phase II drugs for Vasomotor Symptoms of Menopause (Hot Flashes) have a 54% phase transition success rate (PTSR) indication benchmark for progressing into Phase III.

Menopause is a huge mental, emotional and physical change. Here's what you need to know about this stage of life, including ...

For many women who experience hot flashes, the new drug Veozah has been a life-changer. And a heightened warning last month, doesn’t seem to be dampening that enthusiasm.

The US Food and Drug Administration (FDA) has approved datopotamab deruxtecan for the treatment of certain patients with unresectable or metastatic hormone receptor (HR)-positive, human epidermal ...

Axatilimab has gained FDA approval in 9 mg and 22 mg vials, expanding treatment options for patients with chronic GVHD after 2 prior therapy failures. The FDA has granted approval to axatilimab-csfr ...

A study published by the North American Menopause Society in the journal Menopause, found a plant-based diet rich in soy reduces moderate-to-severe hot flashes by 84%, from nearly five per day to ...

Acalabrutinib received FDA approval for MCL as monotherapy and in combination with bendamustine and rituximab. The ECHO trial showed a 27% reduction in death risk and 34% improvement in ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly’s Zepbound ...

Dosage of Opdivo Qvantig varies by indication and is based on disease progression and toxicity. Opdivo Qvantig received FDA approval for all previously approved indications in solid tumors. The Food ...